Ilixadencel – an Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration

por Karlsson-Parra, Alex, Kovacka, Juliana, Heimann, Emilia, Jorvid, Margareth, Zeilemaker, Sijme, Longhurst, Sharon, Suenaert, Peter
Publicado 2018

Engineered bacteria to accelerate wound healing: an adaptive, randomised, double-blind, placebo-controlled, first-in-human phase 1 trial

por Öhnstedt, Emelie, Vågesjö, Evelina, Fasth, Andreas, Lofton Tomenius, Hava, Dahg, Pia, Jönsson, Sofia, Tyagi, Nisha, Åström, Mikael, Myktybekova, Zhanar, Ringstad, Lovisa, Jorvid, Margareth, Frank, Peter, Hedén, Per, Roos, Stefan, Phillipson, Mia
Publicado 2023